Vext Strengthens Ohio Presence with Dispensary Property Acquisition

Rhea-AI Summary

Vext Science, Inc. completes the acquisition of real property associated with a cannabis dispensary in Athens, Ohio as part of the Ohio Expansion Transaction. The Company paid $2.6 million for the acquisition, with $0.9 million in cash and a $1.7 million promissory note at 7.0% interest repayable over 10 years. The acquisition is expected to be completed by the end of 2024.

Vancouver, British Columbia--(Newsfile Corp. - April 8, 2024) - Vext Science, Inc.  (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it has completed the acquisition (the "Property Acquisition") of real property associated with a cannabis dispensary in Athens, Ohio as part of the previously disclosed Ohio Expansion Transaction. As consideration for the Property Acquisition, the Company has paid aggregate consideration of $2.6 million, consisting of $0.9 million in cash and the issuance of a promissory note in the principal amount of $1.7 million (the "Promissory Note"). The Promissory Note bears interest at the rate of 7.0% per annum and is repayable over a period of 10 years, maturing on April 4, 2034.

For further details of the Ohio Expansion Transaction, please see the Company's news releases dated October 2, 2023 and October 16, 2023 and the full text of the Asset Purchase Agreement governing the Ohio Expansion Transaction, which is available under the Company's SEDAR+ profile at www.sedarplus.ca. The Company currently expects that the acquisition of the two Ohio dispensaries under the Ohio Expansion Transaction, together with related licenses and all other assets of such dispensaries, will be completed by the end of 2024.

Unless otherwise noted, all currency references used in this news release are in U.S. currency.

About Vext Science, Inc.

Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio, as well as through Vext's partnerships in other states. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations, with the Company having operated profitably since 2016. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.

Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.

For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to the Property Acquisition, including the repayment of the Promissory Note, statements related to the Ohio Expansion Transaction, including the anticipated closing date and receipt of regulatory approvals related thereto, and other statements regarding future developments and the business and operations of the Vext, market projections of the cannabis industry in Ohio, and the Company's business plans in Ohio, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at www.sedarplus.ca.

Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Eric Offenberger
Chief Executive Officer
844-211-3725

For further information:
Jonathan Ross, Vext Investor Relations
jon.ross@loderockadvisors.com
416-244-9851

SOURCE: Vext Science, Inc

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/204489

FAQ

What did Vext Science, Inc. acquire as part of the Ohio Expansion Transaction?

Vext Science, Inc. acquired real property associated with a cannabis dispensary in Athens, Ohio.

How much did Vext Science, Inc. pay for the acquisition?

Vext Science, Inc. paid $2.6 million for the acquisition, consisting of $0.9 million in cash and a $1.7 million promissory note.

What is the interest rate on the promissory note?

The promissory note bears interest at the rate of 7.0% per annum.

When is the promissory note repayable?

The promissory note is repayable over a period of 10 years, maturing on April 4, 2034.

Where can further details of the Ohio Expansion Transaction be found?

Further details of the Ohio Expansion Transaction can be found in the Company's news releases dated October 2, 2023, and October 16, 2023, as well as the full text of the Asset Purchase Agreement available under the Company's SEDAR+ profile at www.sedarplus.ca.